Drugs & Medications
-
AFP CLINICAL ANSWERS APRIL, 2026
This is the second article based on information presented the American Family Physician journal’s section titled “Clinical Answers.” The April…
Read More » -
IVERMECTIN: FOR CANCER?
Over the past 5 to 10 years, no drug has been more controversial than Ivermectin. All the uproar during the…
Read More » -
GLP-1’S AND BREAST CANCER SURVIVAL
Who isn’t taking a GLP-1 these days? There are so many reasons for doctors to prescribe them that almost everyone…
Read More » -
ADVERSE EFFECTS OF GLP-1’S
Literally every day I read something about Glucagon Like Peptide-1Receptor Agonists, GLP-RA’s. That’s the million dollar name for the class…
Read More » -
QUICK MEDICAL ADVICE FROM THE AAFP
American Family Physician is the scientific journal of the American Academy of Family Physicians (the AAFP). The AAFP is the…
Read More » -
FDA APPROVES ORAL GLP-1
Eli Lilly and Co. of Indianapolis nearly has a corner on the GLP-1 market. Their GLP-1, tirzepatide, has been a…
Read More » -
LOW-DOSE ORAL MINOXIDIL FOR MALE PATTERN BALDNESS
Androgenetic alopecia is the scientific name given to male-pattern baldness. Alopecia is the medical term for hair loss of any…
Read More » -
ADDITIVES IN ILLICIT DRUGS
If you didn’t already know, makers of illicit drugs include “additives and contaminants” in the opioid drugs they produce to…
Read More » -
GLP-1’S AND ALCOHOL
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1’s) have been discussed in this blog numerous times. This post is another that focuses on…
Read More » -
ELI LILLY DOESN’T MISS AN OPPORTUNITY
Eli Lilly and company, the pharmaceutical giant headquartered in Indianapolis, does not miss an opportunity. They have top notch researchers…
Read More »
